| 000 | 01708 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513103323.0 | ||
| 264 | 0 | _c19970224 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0918-6158 | ||
| 024 | 7 |
_a10.1248/bpb.19.1184 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSagara, K | |
| 245 | 0 | 0 |
_aGastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _cSep 1996 |
||
| 300 |
_a1184-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aBenzopyrans _xadministration & dosage |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aCholinergic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xadministration & dosage |
| 650 | 0 | 4 |
_aDigestive System _xdrug effects |
| 650 | 0 | 4 | _aDigestive System Physiological Phenomena |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPentagastrin _xpharmacology |
| 650 | 0 | 4 | _aPharmacokinetics |
| 650 | 0 | 4 |
_aPropionates _xadministration & dosage |
| 650 | 0 | 4 | _aSolubility |
| 700 | 1 | _aYamada, I | |
| 700 | 1 | _aMatsuura, Y | |
| 700 | 1 | _aKawata, M | |
| 700 | 1 | _aShibata, M | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 19 _gno. 9 _gp. 1184-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.19.1184 _zAvailable from publisher's website |
| 999 |
_c8881685 _d8881685 |
||